(Press-News.org) Sara Clasen is the 2023 winner of the NOSTER & Science Microbiome Prize for her work in illuminating how “silent flagellins” from commensal microbiota evade a host’s innate immunity.
The NOSTER & Science Microbiome Prize aims to reward innovative research from young investigators working on the functional attributes of the microbiota of any organism that has potential to contribute to our understanding of health and disease, or to guide novel therapeutic interventions.
Strong adaptive immune responses require activation of innate immunity. To do this, innate immune receptors respond to conserved molecules, or ligands, produced by a pathogen. But these ligands are also produced by trillions of microbes that inhabit the gut microbiome – the vast majority of which are nonpathogenic and beneficial to human health. How innate immune receptors tolerate ligands from non-pathogens while recognizing those from pathogens remains poorly understood.
To address this question, Clasen, and her laboratory focused on the Toll-like receptor 5 (TLR5) and its ligand, flagellin. Both pathogenic and commensal bacteria produce flagellins – a crucial protein used to build the filaments used for microbial locomotion. When these filaments break down, they are recognized by TLR5, which binds flagellin and initiates a pro-inflammatory response.
Although this response is well characterized for pathogens like Salmonella, TLR5 response to commensal-derived flagellins remains poorly understood. Clasen identified and characterized the interactions between TLR5 and 40 flagellins that are abundant in the human microbiome and discovered so-called “silent flagellins,” which strongly bind but weakly activate TLR5.
According to the findings, unlike pathogen-derived flagellins, these flagellins lack a secondary TLR5 binding site, which mediates their immune receptor response.
“Our discovery of silent flagellins illustrates one way by which innate immune receptors tolerate ligands from commensals,” writes Clasen.
Clasen’s prize-winning essay will be published in the July 7 issue of Science.
Finalists
Christopher Stewart is a finalist for his essay “Diet-microbe-host interaction in early life: breastmilk bioactives are important to infant microbiome,” which focused on the impact of human milk oligosaccharides in maternal milk on the developing infant gut microbiome. Stewart receivedgraduate degrees and a Ph.D. from Northumbria University. After completing a postdoctoral fellowship at Baylor College of Medicine, Steward started his lab in the Translational and Clinical Research Institute at Newcastle University. His research is focused on microbial-host interaction in the gut of infants born premature.
Christoph Thaiss is a finalist for his essay “A microbiome exercise: gut-brain connections drive the motivation to work out,” which focused on the microbiome’s role in exercise performance and benefits. Thaiss received his undergraduate degrees from the University of Bonn, Y?ale University, and ETH Zürich, and a Ph.D. from the Weizmann Institute of Science. After completing his doctoral training, Thaiss founded his lab in the Microbiology Department of the Perelman School of Medicine at the Unviersity of Pennsylvania where his research focuses on the multifaceted interactions between environmental factors, the gut microbiome, the immune system, metabolism, and the brain.
###
About Science/AAAS
The American Association for the Advancement of Science (AAAS) is the world's largest general scientific society and publisher of the journal Science, as well as Science Translational Medicine; Science Signaling; a digital, open-access journal, Science Advances; Science Immunology; and Science Robotics. AAAS was founded in 1848 and includes more than 250 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world. The nonprofit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives in science policy, international programs, science education, public engagement and more.
About NOSTER
Noster was incorporated on May 15, 2020, in Kyoto, Japan, specializing in the research and development of gut microbiome-based treatments with the vision of "connecting life and gut microbiome." The company's mission is to elucidate the functions of over 1,000 species of human gut microorganisms--numbering over 100 trillion--that exist symbiotically with humans, and to contribute to scientific advances in microbiotics to improve the health of people worldwide. Recent research shows that immune and digestive diseases as well as certain cancers are linked to the gut microbiome, making it an obvious target for the development of new biotherapy treatments based on manipulating the abundance and biology of gut microorganisms. To solidify its future, Noster is exploiting its deep understanding of the gut microbiome by building a unique library of intestinal microbes and their metabolites, referred to as "postbiotics." Using this library, company scientists are working passionately to realize breakthroughs in drug discovery and to develop innovative therapeutic treatments targeting the gut microbiome.
END
Prize winner reveals how commensal-derived “silent” flagellins evade innate immunity
2023-07-06
ELSE PRESS RELEASES FROM THIS DATE:
Researchers demonstrate first visible wavelength femtosecond fiber laser
2023-07-06
WASHINGTON — Researchers have developed the first fiber laser that can produce femtosecond pulses in the visible range of the electromagnetic spectrum. Fiber lasers producing ultrashort, bright visible-wavelength pulses could be useful for a variety of biomedical applications as well as other areas such as material processing.
Visible femtosecond pulses are usually obtained using complex and inherently inefficient setups. Although fiber lasers represent a very promising alternative due to their ruggedness/reliability, small footprint, efficiency, lower cost and high brightness, it hasn’t been possible, until now, to produce visible pulses with durations in the femtosecond ...
Top corn producing state to see future drop in yield, cover crop efficiency
2023-07-06
URBANA, Ill. — Winter cover crops could cut nitrogen pollution in Illinois’ agricultural drainage water up to 30%, according to recent research from the University of Illinois Urbana-Champaign. But how will future climate change affect nitrogen loss, and will cover crops still be up to the job? A new study investigating near- and far-term climate change in Illinois suggests cover crops will still be beneficial, but not to the same degree. The report also forecasts corn ...
New study: Black women with hypertensive disorders of pregnancy have increased stroke risk
2023-07-06
(Boston) – U.S. Black women have a disproportionately higher burden of both preeclamptic pregnancy and stroke compared with white women, but virtually all existing evidence on the association between the two medical conditions has come from studies of white women.
A newly published study focuses on data gathered over 25 years from 59,000 Black women in the Black Women’s Health Study (BWHS) and is led by researchers from Boston University Chobanian & Avedisian School of Medicine and Slone Epidemiology Center. The study, published in the New England Journal of Medicine Evidence, ...
Bezos Earth Fund grants $12 million to Smithsonian to support major forest carbon project
2023-07-06
By conserving and replanting forests, the world buys time until it brings other climate and sustainability solutions online. As a critical step toward this goal, the Smithsonian Tropical Research Institute (STRI) received a $12 million grant from the Bezos Earth Fund to support GEO-TREES. This international consortium is the first worldwide system to independently ensure the accuracy of satellite monitoring of forest biomass—a way to measure carbon stored in trees—in all forest types and conditions. The GEO-TREES alliance offers a freely accessible database that integrates ...
Legends of Norse Settlers drove Denmark towards Greenland
2023-07-06
In 985, Viking explorer Erik the Red led a group of Icelandic farmers to Greenland, where they established a settlement on the west coast. Archaeological evidence suggests that the settlement existed for over 400 years, but the impact of the settlement lasted much longer. It is little recognised today that the hope of finding the descendants of the settlers dominated European and American perspectives on Greenland for centuries
In his new book The Vanished Settlers of Greenland: In Search of a Legend and Its Legacy, Associate Professor Robert Rix argues that the lost Norse settlement played a decisive ...
Archaeology: The power of the Copper Age 'Ivory Lady' revealed
2023-07-06
The highest status individual in ancient Copper Age society in Iberia, was a woman and not a man as previously thought, according to peptide analysis reported in Scientific Reports. The individual, now re-dubbed the 'Ivory Lady', was buried in a tomb filled with the largest collection of rare and valuable items in the region, including ivory tusks, high-quality flint, ostrich eggshell, amber, and a rock crystal dagger. These findings reveal the high status women could hold in this ancient society.
In 2008, an individual was discovered in a tomb in Valencia, Spain dating to the Copper Age between 3,200 and 2,200 years ago. As well as being a rare example of a single occupancy ...
Schizophrenia is associated with somatic mutations occurring in utero
2023-07-06
As a psychiatric disorder with onset in adulthood, schizophrenia is thought to be triggered by some combination of environmental factors and genetics, although the exact cause is still not fully understood. In a study published in the journal Cell Genomics on July 6, researchers find a correlation between schizophrenia and somatic copy-number variants, a type of mutation that occurs early in development but after genetic material is inherited. This study is one of the first to rigorously describe the relationship between somatic—not inherited—genetic mutations and schizophrenia risk.
“We originally thought of genetics as the study of inheritance. But now we ...
Team develops all-species coronavirus test
2023-07-06
CHAMPAIGN, Ill. — In an advance that will help scientists track coronavirus variants in wild and domesticated animals, researchers report they can now detect exposure to the SARS-CoV-2 virus in any animal species. Most coronavirus antibody tests require specialized chemical reagents to detect host antibody responses against the virus in each species tested, impeding research across species.
The virus that causes COVID-19 in humans also infects a variety of animals, said University of Illinois Urbana-Champaign pathobiology professor and virologist Ying Fang, who led the new research. So far, ...
Shrinking Arctic glaciers are unearthing a new source of methane
2023-07-06
As the Arctic warms, shrinking glaciers are exposing bubbling groundwater springs which could provide an underestimated source of the potent greenhouse gas methane, finds new research published today in Nature Geoscience.
The study, led by researchers from the University of Cambridge and the University Centre in Svalbard, Norway, identified large stocks of methane gas leaking from groundwater springs unveiled by melting glaciers.
The research suggests that these methane emissions will likely increase as Arctic glaciers retreat and more ...
Health outcomes, cost-effectiveness of monoclonal SARS-CoV-2 antibodies as pre-exposure prophylaxis
2023-07-06
About The Study: This decision analytic model showed that within the context of a high SARS-CoV-2 probability, monoclonal antibodies pre-exposure prophylaxis (mAbs PrEP) provision was cost-saving when provided to individuals at increased risk of severe COVID-19 if drug prices decrease to $275 and effectiveness is 75% or higher. When newer mAbs PrEP combinations become available, guidance on implementation should be formulated ensuring a fast rollout. Nevertheless, advocacy for mAbs PrEP use and critical discussion on drug prices are necessary to ensuring cost-effectiveness for different epidemic settings.
Authors: Stephanie Popping, M.D., Ph.D., of the University ...